Search hospitals
>
Illinois
>
Chicago
University of Illinois Cancer Center
Claim this profile
Chicago, Illinois 60612
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Prostate Cancer
118 reported clinical trials
16 medical researchers
Summary
University of Illinois Cancer Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Leukemia, Lymphoma, Prostate Cancer and other specialties. University of Illinois Cancer Center is involved with conducting 118 clinical trials across 176 conditions. There are 16 research doctors associated with this hospital, such as Lawrence E. Feldman, Shikha Jain, Paul Rubinstein, MD, and Oana Danciu.
Area of expertise
Lung Cancer
University of Illinois Cancer Center has run 23 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
University of Illinois Cancer Center has run 22 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Lawrence E. Feldman
University of Illinois
6 years of reported clinical research
Shikha Jain
University of Illinois
7 years of reported clinical research
Paul Rubinstein, MD
University of Illinois
3 years of reported clinical research
Oana Danciu
University of Illinois
10 years of reported clinical research
Clinical Trials running at University of Illinois Cancer Center
Breast Cancer
Lung Cancer
Endometrial Cancer
Ovarian Cancer
Cervical Cancer
Esophageal Cancer
Bladder Cancer
Multiple Myeloma
Lymphoma
Squamous Cell Carcinoma
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sacituzumab tirumotecan alone or with pembrolizumab live longer overall or without the cancer growing or spreading compared to people treated with chemotherapy.
Recruiting
2 awards
Phase 3
3 criteria
Low Dose Azacitidine
for Early Stage Breast Cancer
This trial is testing if low dose azacitidine can help the immune system fight high-risk early stage breast cancer. The treatment aims to increase immune cells that attack cancer cells. It targets patients whose cancer is more likely to return or spread.
Recruiting
1 award
Phase 2
10 criteria
BL-M07D1
for HER2-Positive Cancer
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.
Recruiting
1 award
Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Illinois Cancer Center?
University of Illinois Cancer Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Leukemia, Lymphoma, Prostate Cancer and other specialties. University of Illinois Cancer Center is involved with conducting 118 clinical trials across 176 conditions. There are 16 research doctors associated with this hospital, such as Lawrence E. Feldman, Shikha Jain, Paul Rubinstein, MD, and Oana Danciu.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.